Evidence map›Paper›PMID 34420044›Full record

ArticleMucosal immunology2022

Loss of protein tyrosine phosphatase non-receptor type 2 reduces IL-4-driven alternative macrophage activation.

Marianne R Spalinger, Meli'sa Crawford, Sarah D Bobardt, Jiang Li, Anica Sayoc-Becerra, Alina N Santos, Ali Shawki, Pritha Chatterjee, Meera G Nair, Declan F McCole

Open access · hybridAbstract read
In one paragraph

Article in Mucosal immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease.The Journal of allergy and clinical immunology · 2022
    Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Marianne R SpalingerDivision of Biomedical Sciences, University of California Riverside, Riverside, CA, USA. marianne.spalinger@usz.ch.ORCID http://orcid.org/0000-0003-4498-0058
Meli'sa CrawfordDivision of Biomedical Sciences, University of California Riverside, Riverside, CA, USA.
Sarah D BobardtDivision of Biomedical Sciences, University of California Riverside, Riverside, CA, USA.
Jiang LiDivision of Biomedical Sciences, University of California Riverside, Riverside, CA, USA.
Anica Sayoc-BecerraDivision of Biomedical Sciences, University of California Riverside, Riverside, CA, USA.
Alina N SantosDivision of Biomedical Sciences, University of California Riverside, Riverside, CA, USA.
Ali ShawkiDivision of Biomedical Sciences, University of California Riverside, Riverside, CA, USA.
Pritha ChatterjeeDivision of Biomedical Sciences, University of California Riverside, Riverside, CA, USA.
Meera G NairDivision of Biomedical Sciences, University of California Riverside, Riverside, CA, USA.
Declan F McColeDivision of Biomedical Sciences, University of California Riverside, Riverside, CA, USA.
University of California, Riverside · US

Funding

A NOVEL ROLE FOR PTPN2 IN INTESTINAL EPITHELIAL BARRIER REGULATIONR01DK091281 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Declan McCole · 2012 to 2026
$5.5M
RELMalpha-expressing macrophages mediate host disease tolerance in mucosal infectionR01AI153195 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI NAIR, MEERA GOH · 2020 to 2024
$3.5M
Tyrosine Phosphatase Regulation of Mucosal Macrophage-Epithelial Cell Cross-talkR01AI153314 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI MCCOLE, DECLAN · 2020 to 2024
$2.5M
NIAID NIH HHS R01 AI153195NIAID NIH HHS R01 AI153314NIDDK NIH HHS R01 DK091281
6 · The paper itself

Abstract

Macrophages are a heterogeneous population of innate immune cells that are often divided into two major subsets: classically activated, typically pro-inflammatory (M1) macrophages that mediate host defense, and alternatively activated, tolerance-inducing (M2) macrophages that exert homeostatic and tissue-regenerative functions. Disturbed macrophage function/differentiation results either in inadequate, excessive immune activation or in a failure to induce efficient protective immune responses against pathogens. Loss-of-function variants in protein tyrosine phosphatase non-receptor type 2 (PTPN2) are associated with chronic inflammatory disorders, but the effect of macrophage-intrinsic PTPN2 loss is still poorly understood. Here we report that PTPN2-deficient macrophages fail to acquire an alternatively activated/M2 phenotype. This was the consequence of reduced IL-6 receptor expression and a failure to induce IL-4 receptor in response to IL-6, resulting in an inability to respond to the key M2-inducing cytokine IL-4. Ultimately, failure to adequately respond to IL-6 and IL-4 resulted in increased levels of M1 macrophage marker expression in vitro and exacerbated lung inflammation upon infection with Nippostrongylus brasiliensis in vivo. These results demonstrate that PTPN2 loss interferes with the ability of macrophages to adequately respond to inflammatory stimuli and might explain the increased susceptibility of PTPN2 loss-of-function carriers to developing inflammatory diseases.

Indexed as

AnimalsCell DifferentiationGene Knockdown TechniquesHumansInflammationInterleukin-4LungMacrophagesMiceMice, KnockoutNippostrongylusProtein Tyrosine Phosphatase, Non-Receptor Type 2Strongylida InfectionsTh1 CellsTh2 CellsTHP-1 CellsInterleukin-4Protein Tyrosine Phosphatase, Non-Receptor Type 2PTPN2 protein, humanPtpn2 protein, mouse

Identifiers

PMID34420044
PMCPMC8732276
OpenAlexW3193765659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.